Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease.
- DOI
- 10.1002/alz.70639
- Published
- 2025 Sep
- Container
- Alzheimer's & dementia : the journal of the Alzheimer's Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.70639,
title = {Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease.},
author = {Zhang P and Mao C and Sun A and Yang Y and Hou Y and Fu Z and Babak T and Leverenz JB and Pieper AA and Luo Y and Cummings J and Cheng F},
year = {2025},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
doi = {10.1002/alz.70639},
url = {https://doi.org/10.1002/alz.70639}
}RIS
TY - JOUR TI - Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease. AU - Zhang P AU - Mao C AU - Sun A AU - Yang Y AU - Hou Y AU - Fu Z AU - Babak T AU - Leverenz JB AU - Pieper AA AU - Luo Y AU - Cummings J AU - Cheng F PY - 2025 JO - Alzheimer's & dementia : the journal of the Alzheimer's Association DO - 10.1002/alz.70639 UR - https://doi.org/10.1002/alz.70639 ER -
APA
P, Z., C, M., A, S., Y, Y., Y, H., Z, F., T, B., JB, L., AA, P., Y, L., J, C., & F, C. (2025). Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.70639
Source records
- pubmed · retrieved 2026-09-25T02:32:50.094Z